Yong Song Selected Research

Yong Song Research Topics

Disease

101	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2008
85	Neoplasms (Cancer) 07/2022 - 07/2004
57	Lung Neoplasms (Lung Cancer) 02/2022 - 04/2008
31	Adenocarcinoma of Lung 01/2022 - 10/2009
25	Neoplasm Metastasis (Metastasis) 08/2021 - 09/2009
20	Inflammation (Inflammations) 04/2022 - 09/2003
15	Acute Lung Injury 04/2022 - 04/2003
13	Lung Injury 04/2022 - 10/2009
12	Carcinogenesis 07/2022 - 09/2009
10	Disease Progression 10/2022 - 09/2013
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2013
9	Malignant Pleural Effusion 09/2019 - 01/2012
8	Pneumonia (Pneumonitis) 01/2021 - 01/2014
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 09/2009
7	Pleural Effusion (Pleural Effusions) 04/2020 - 01/2012
7	Exanthema (Rash) 01/2020 - 01/2013
7	Asthma (Bronchial Asthma) 01/2019 - 03/2007
7	Hemorrhagic Shock 01/2009 - 04/2003
6	Carcinoma (Carcinomatosis) 01/2022 - 09/2009
6	Adenocarcinoma 12/2021 - 09/2009
6	Endometriosis 01/2020 - 04/2013
5	Sepsis (Septicemia) 04/2022 - 08/2002
5	Brain Neoplasms (Brain Tumor) 02/2022 - 01/2017
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 01/2009
5	Lymphatic Metastasis 01/2017 - 01/2009
5	Lung Diseases (Lung Disease) 06/2015 - 04/2008
4	Necrosis 01/2022 - 12/2006
4	Food Hypersensitivity (Food Allergy) 02/2021 - 01/2017
4	Hemorrhage 02/2021 - 04/2003
4	Insulin Resistance 04/2016 - 11/2011
3	Wounds and Injuries (Trauma) 06/2022 - 01/2013
3	Breast Neoplasms (Breast Cancer) 06/2021 - 04/2015
3	Granuloma 04/2020 - 06/2003
3	Hypertension (High Blood Pressure) 01/2020 - 01/2013
3	Hypoxia (Hypoxemia) 01/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

34	Biomarkers (Surrogate Marker)IBA 02/2022 - 07/2004
32	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2009
26	ErbB Receptors (EGF Receptor)IBA 08/2021 - 03/2011
14	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2011
13	Long Noncoding RNAIBA 09/2022 - 04/2015
12	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2017
10	RNA (Ribonucleic Acid)IBA 06/2022 - 04/2004
9	Biological ProductsIBA 02/2022 - 06/2012
9	MicroRNAs (MicroRNA)IBA 08/2021 - 09/2012
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2009
9	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2013
9	Messenger RNA (mRNA)IBA 01/2019 - 09/2005
8	CytokinesIBA 04/2022 - 07/2012
8	PlatinumIBA 01/2021 - 03/2011
8	icotinibIBA 02/2020 - 09/2013
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 04/2003
7	LipopolysaccharidesIBA 01/2021 - 09/2005
6	CrizotinibIBA 01/2020 - 01/2015
6	Pharmaceutical PreparationsIBA 12/2019 - 07/2010
5	Gefitinib (Iressa)FDA Link 12/2020 - 03/2011
5	Cadherins (E-Cadherin)IBA 10/2019 - 11/2013
5	CateninsIBA 02/2017 - 04/2015
4	Topotecan (Hycamtin)FDA LinkGeneric 04/2022 - 10/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2012
4	VimentinIBA 12/2021 - 11/2013
4	Carcinoembryonic AntigenIBA 08/2021 - 04/2014
4	osimertinibIBA 08/2021 - 01/2019
4	AlbuminsIBA 03/2021 - 09/2014
4	LigandsIBA 02/2021 - 04/2015
4	Circulating Tumor DNAIBA 01/2021 - 04/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 03/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2012
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2014
4	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2021 - 01/2018
4	Docetaxel (Taxotere)FDA Link 05/2020 - 07/2014
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 09/2005
4	Mitochondrial DNA (mtDNA)IBA 11/2019 - 01/2013
4	Anaplastic Lymphoma KinaseIBA 05/2018 - 01/2015
4	HMGB1 Protein (HMG1)IBA 10/2017 - 09/2009
4	enhanced green fluorescent proteinIBA 09/2012 - 07/2010
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2012 - 08/2002
3	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2022 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2014
3	Gemcitabine FDA Link 01/2022 - 09/2014
3	Tumor Biomarkers (Tumor Markers)IBA 12/2021 - 02/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 09/2011
3	Alanine Transaminase (SGPT)IBA 02/2021 - 01/2017
3	AntibodiesIBA 01/2021 - 02/2009
3	Pemetrexed (MTA)FDA Link 10/2020 - 02/2015
3	ImmunosorbentsIBA 01/2020 - 05/2014
3	EnzymesIBA 01/2020 - 05/2014
3	growth arrest specific transcript 5IBA 11/2019 - 02/2016
3	ORALIT (ORS)IBA 08/2019 - 10/2009
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2014
3	130-nm albumin-bound paclitaxelIBA 01/2019 - 09/2014
3	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2014
3	AllergensIBA 10/2017 - 05/2011

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
34	Therapeutics 10/2022 - 12/2008
12	Immunotherapy 12/2021 - 03/2014
6	Punctures 04/2022 - 09/2005
6	Radiotherapy 01/2022 - 09/2009
5	Artificial Respiration (Mechanical Ventilation) 02/2022 - 05/2014